Trials / Completed
CompletedNCT01826149
Propofol Effects on Mitral Valve Annular Velocity
The Effect of Propofol on Tissue Doppler Imaging of Mitral Valve Annular Velocity During Remifentanil-based Cardiac Anesthesia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Konkuk University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is primarily to determine the effects of propofol at different concentration on the mitral valve annulus by using Tissue Doppler Imaging
Detailed description
The purpose of this study is to evaluate the effects of different concentration of propofol on patients who are undergoing cardiac surgery. The patients will receive infusion remifentanil 0.5mcg/kg/min with different target-site propofol concentration namely 1.0ng/ml, 2.0ng/ml and 3.0ng/ml. Tissue Doppler Imaging by transesophageal echocardiography will be done to assess the changes in cardiac function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol 1.0mcg | Propofol dosage titration to achieve effect site concnetration at 1.0 mcg/ml using target controlled infusion. |
| DRUG | Propofol 2.0mcg | Propofol dosage titration to achieve effect site concnetration at 2.0 mcg/ml using target controlled infusion. |
| DRUG | Propofol 3.0mcg | Propofol dosage titration to achieve effect site concnetration at 3.0 mcg/ml using target controlled infusion |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-12-01
- First posted
- 2013-04-08
- Last updated
- 2016-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01826149. Inclusion in this directory is not an endorsement.